Cannabichromene (CBC) Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 135 studies associated with Cannabichromene (CBC).
Here is a small sampling of Cannabichromene (CBC) studies by title:
- Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
- Therapeutic potential of cannabidiol-rich Cannabis sativa to mitigate the severity of inflammation and pain: A pre-clinical study
- Anticancer effect of minor phytocannabinoids in preclinical models of multiple myeloma
- Exploring the Potential of Synthetic Cannabinoids: Modulation of Biological Activity of Normal and Cancerous Human Colon Epithelial Cells
- Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports ApplicationsArticle link copied!
Ready to become a subscriber? Go to our PRICING page. Want to learn more about Endocannabinoid Medicine? Buy a book.
Endocannabinoid Medicine: 11 Keys to Deeper Healing
Your body already carries the keys to healing. At the center of it all is the endocannabinoid system (ECS)—a hidden bridge between body, mind, and spirit that works quietly in the background to restore balance, ease pain, calm stress, and support resilience.
Buy Book
Cannabis for Chronic Pain Relief: A Dual Guide for Patients and Clinicians
Chronic pain impacts one in four people, yet safe and effective long-term treatments remain limited. This practical guide offers an evidence-based algorithmic framework for using cannabis and cannabinoids with clarity and confidence.
Buy BookPage Quick Links
Select New Cannabinoid
Overview - Cannabichromene (CBC)
Description of Cannabichromene (CBC)
Cannabichromene (CBC) was first isolated from hashish by Rafael Mechoulam and Y. Gaoni in 1966. By 2016 there were nine distinct members in the CBC family.
One of its unique characteristics is that CBC is a relatively stable cannabinoid that has been found in century-old samples of cannabis.
Other Names:
CannabichromeneCannabichrome, Cannanbichromene, Pentylcannabichromene, (+/-)-Cannabichromene plus numerous other supplier-based synonyms.
IUPAC Name: 2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromen-5-ol
Molecular Formula: C21H30O2
Source–PubChem
Cannabichromene (CBC) Properties and Effects
Only Members can view Properties and Effects information. See DEMO page.
Cannabichromene (CBC) Receptor Binding
Only Members can view Receptor Binding information. See DEMO page.
Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You
should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a
medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
